• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症干细胞标志物 Bmi-1 的表达与乳腺癌的基底样表型和不良预后相关。

Cancer stem cell marker Bmi-1 expression is associated with basal-like phenotype and poor survival in breast cancer.

机构信息

Department of Radiation Oncology, General Hospital of Ningxia Medical University, Yinchuan, No. 804 Shengli Str, Yinchuan, 750004, Ningxia, China.

Department of Surgical Oncology, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.

出版信息

World J Surg. 2012 May;36(5):1189-1194. doi: 10.1007/s00268-012-1514-3.

DOI:10.1007/s00268-012-1514-3
PMID:22366984
Abstract

BACKGROUND

The purpose of present study was to examine the expression of cancer stem cell marker Bmi-1 in breast cancer tissue and to evaluate the clinical implication of Bmi-1 expression for these patients.

METHODS

A total of 171 breast cancer patients who received surgical treatment in our hospital were enrolled in this study. Bmi-1 expression in breast cancer tissue was assayed by immunohistochemistry. Statistical analyses were applied to test the relationship between expression of Bmi-1 and clinicopathologic features and patient survival. The relationship between Bmi-1 and the basal-like phenotype of breast cancer also was analyzed in this study.

RESULTS

Positive Bmi-1 expression was detected in 89 of 171 (52%) invasive breast cancers patients. The Bmi-1 status was significantly correlated to histological grade III (p = 0.001) and basal-like phenotype (p < 0.001). The 5 year overall survival of the patients with Bmi-1-positive and -negative cancers were 78 and 91.9%, respectively (p = 0.03). Histological grade (p = 0.046) and Bmi-1 status (p = 0.012) were detected as the independent prognostic factors in the Cox regression test.

CONCLUSIONS

Bmi-1 status is an independent prognostic factor, which also is associated with tumor histological grade and basal-like phenotype. The high proportions of positive Bmi-1 expression in basal-like breast cancer may be related to the high aggressiveness behavior of this subtype of breast cancer.

摘要

背景

本研究旨在检测乳腺癌组织中癌症干细胞标志物 Bmi-1 的表达,并评估 Bmi-1 表达对这些患者的临床意义。

方法

本研究共纳入 171 例在我院接受手术治疗的乳腺癌患者。采用免疫组织化学法检测乳腺癌组织中 Bmi-1 的表达。应用统计学分析检测 Bmi-1 表达与临床病理特征和患者生存之间的关系。本研究还分析了 Bmi-1 与乳腺癌基底样表型之间的关系。

结果

在 171 例浸润性乳腺癌患者中,89 例(52%)检测到 Bmi-1 阳性表达。Bmi-1 状态与组织学分级 III(p = 0.001)和基底样表型(p < 0.001)显著相关。Bmi-1 阳性和阴性癌症患者的 5 年总生存率分别为 78%和 91.9%(p = 0.03)。组织学分级(p = 0.046)和 Bmi-1 状态(p = 0.012)是 Cox 回归检验中独立的预后因素。

结论

Bmi-1 状态是一个独立的预后因素,与肿瘤组织学分级和基底样表型相关。基底样乳腺癌中 Bmi-1 阳性表达率较高,可能与该亚型乳腺癌侵袭性较高有关。

相似文献

1
Cancer stem cell marker Bmi-1 expression is associated with basal-like phenotype and poor survival in breast cancer.癌症干细胞标志物 Bmi-1 的表达与乳腺癌的基底样表型和不良预后相关。
World J Surg. 2012 May;36(5):1189-1194. doi: 10.1007/s00268-012-1514-3.
2
Independent prognostic value of the basal-like phenotype of breast cancer and associations with EGFR and candidate stem cell marker BMI-1.乳腺癌基底样表型的独立预后价值及其与表皮生长因子受体(EGFR)和候选干细胞标志物BMI-1的关联
Histopathology. 2008 Feb;52(3):370-80. doi: 10.1111/j.1365-2559.2007.02957.x.
3
[Expression and significance of Bmi-1 in breast cancer].Bmi-1在乳腺癌中的表达及意义
Ai Zheng. 2007 Feb;26(2):154-7.
4
P-cadherin expression as a prognostic biomarker in a 3992 case tissue microarray series of breast cancer.在一个包含 3992 例乳腺癌组织微阵列的系列中,P-钙黏蛋白表达作为一种预后生物标志物。
Mod Pathol. 2011 Jan;24(1):64-81. doi: 10.1038/modpathol.2010.189. Epub 2010 Sep 17.
5
Extracellular matrix 1 (ECM1) expression is a novel prognostic marker for poor long-term survival in breast cancer: a Hospital-based Cohort Study in Iowa.细胞外基质1(ECM1)表达是乳腺癌长期生存不良的一种新的预后标志物:爱荷华州一项基于医院的队列研究
Ann Surg Oncol. 2009 Aug;16(8):2280-7. doi: 10.1245/s10434-009-0533-2. Epub 2009 Jun 12.
6
Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab.磷酸化HER2在接受辅助曲妥珠单抗治疗的HER2阳性乳腺癌患者中的预后价值。
Breast Cancer. 2015 May;22(3):292-9. doi: 10.1007/s12282-013-0478-y. Epub 2013 Jun 8.
7
Overexpression of LAPTM4B: an independent prognostic marker in breast cancer.LAPTM4B 过表达:乳腺癌的一个独立预后标志物。
J Cancer Res Clin Oncol. 2013 Apr;139(4):661-7. doi: 10.1007/s00432-012-1368-y. Epub 2013 Jan 6.
8
Ki67 Frequency in Breast Cancers without Axillary Lymph Node Involvement and its Relation with Disease-free Survival.无腋窝淋巴结转移乳腺癌的Ki67增殖指数及其与无病生存期的关系
Asian Pac J Cancer Prev. 2016;17(3):1347-50. doi: 10.7314/apjcp.2016.17.3.1347.
9
Elevated Hu-Antigen Receptor (HuR) Expression is Associated with Tumor Aggressiveness and Poor Prognosis but not with COX-2 Expression in Invasive Breast Carcinoma Patients.在浸润性乳腺癌患者中,Hu抗原受体(HuR)表达升高与肿瘤侵袭性及预后不良相关,但与环氧合酶-2(COX-2)表达无关。
Pathol Oncol Res. 2018 Jul;24(3):631-640. doi: 10.1007/s12253-017-0288-1. Epub 2017 Aug 14.
10
Bmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancer.BMI-1 促进侵袭和转移,其高表达与乳腺癌的晚期阶段相关。
Mol Cancer. 2011 Jan 28;10(1):10. doi: 10.1186/1476-4598-10-10.

引用本文的文献

1
Profiling of Breast Cancer Stem Cell Types/States Shows the Role of CD44/CD24-ALDH1 as an Independent Prognostic Factor After Neoadjuvant Chemotherapy.乳腺癌干细胞类型/状态分析显示CD44/CD24-ALDH1作为新辅助化疗后独立预后因素的作用。
Int J Mol Sci. 2025 Aug 24;26(17):8219. doi: 10.3390/ijms26178219.
2
Silencing UBQLN2 Enhances the Radiosensitivity of Esophageal Squamous Cell Carcinoma (ESCC) via Activating p38 MAPK.沉默泛素样蛋白2通过激活p38丝裂原活化蛋白激酶增强食管鳞状细胞癌的放射敏感性。
J Oncol. 2023 Jan 5;2023:2339732. doi: 10.1155/2023/2339732. eCollection 2023.
3
Clinical and prognostic significances of cancer stem cell markers in gastric cancer patients: a systematic review and meta-analysis.

本文引用的文献

1
Bmi-1, c-myc, and Snail expression in primary breast cancers and their metastases--elevated Bmi-1 expression in late breast cancer relapses.原发性乳腺癌及其转移灶中的 BMI-1、c-myc 和 Snail 表达——晚期乳腺癌复发中 BMI-1 表达升高。
Virchows Arch. 2011 Jul;459(1):31-9. doi: 10.1007/s00428-011-1096-8. Epub 2011 Jun 3.
2
Overexpression of Bmi-1 in uterine cervical cancer: correlation with clinicopathology and prognosis.Bmi-1 在宫颈癌中的过表达:与临床病理和预后的相关性。
Int J Gynecol Cancer. 2010 Dec;20(9):1597-603.
3
Bmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancer.
胃癌患者中癌症干细胞标志物的临床及预后意义:一项系统评价与荟萃分析
Cancer Cell Int. 2021 Feb 27;21(1):139. doi: 10.1186/s12935-021-01840-z.
4
Epigenetic regulation of cancer stem cell formation and maintenance.癌症干细胞形成和维持的表观遗传调控。
Int J Cancer. 2021 Jun 15;148(12):2884-2897. doi: 10.1002/ijc.33398. Epub 2020 Nov 30.
5
Nrf2 promotes esophageal squamous cell carcinoma (ESCC) resistance to radiotherapy through the CaMKIIα-associated activation of autophagy.Nrf2通过与CaMKIIα相关的自噬激活促进食管鳞状细胞癌(ESCC)对放疗的抗性。
Cell Biosci. 2020 Jul 30;10:90. doi: 10.1186/s13578-020-00456-6. eCollection 2020.
6
The prognostic significance of BMI1 expression in invasive breast cancer is dependent on its molecular subtypes.BMI1 表达在浸润性乳腺癌中的预后意义与其分子亚型相关。
Breast Cancer Res Treat. 2020 Aug;182(3):581-589. doi: 10.1007/s10549-020-05719-x. Epub 2020 Jun 10.
7
BMI‑1 promotes invasion and metastasis in endometrial adenocarcinoma and is a poor prognostic factor.BMI-1 促进子宫内膜腺癌的侵袭和转移,是预后不良的因素。
Oncol Rep. 2020 May;43(5):1630-1640. doi: 10.3892/or.2020.7539. Epub 2020 Mar 10.
8
Kinesin Family Member 11 Enhances the Self-Renewal Ability of Breast Cancer Cells by Participating in the Wnt/β-Catenin Pathway.驱动蛋白家族成员11通过参与Wnt/β-连环蛋白信号通路增强乳腺癌细胞的自我更新能力。
J Breast Cancer. 2019 Dec;22(4):522-532. doi: 10.4048/jbc.2019.22.e51.
9
Advancements in Cancer Stem Cell Isolation and Characterization.癌症干细胞分离与鉴定技术的进展。
Stem Cell Rev Rep. 2019 Dec;15(6):755-773. doi: 10.1007/s12015-019-09912-4.
10
A novel BMI-1 inhibitor QW24 for the treatment of stem-like colorectal cancer.一种新型 BMI-1 抑制剂 QW24 治疗类器官样结直肠癌。
J Exp Clin Cancer Res. 2019 Oct 22;38(1):422. doi: 10.1186/s13046-019-1392-8.
BMI-1 促进侵袭和转移,其高表达与乳腺癌的晚期阶段相关。
Mol Cancer. 2011 Jan 28;10(1):10. doi: 10.1186/1476-4598-10-10.
4
Expression of BMI-1 and Mel-18 in breast tissue--a diagnostic marker in patients with breast cancer.BMI-1 和 Mel-18 在乳腺癌组织中的表达——乳腺癌患者的诊断标志物。
BMC Cancer. 2010 Dec 16;10:686. doi: 10.1186/1471-2407-10-686.
5
Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists.基底样型和三阴性乳腺癌:批判性综述,重点关注对病理学家和肿瘤学家的影响。
Mod Pathol. 2011 Feb;24(2):157-67. doi: 10.1038/modpathol.2010.200. Epub 2010 Nov 12.
6
Overexpression of polycomb protein BMI-1 in human specimens of breast, ovarian, endometrial and cervical cancer.多梳蛋白 BMI-1 在人乳腺癌、卵巢癌、子宫内膜癌和宫颈癌标本中的过表达。
Anticancer Res. 2010 May;30(5):1559-64.
7
Bmi-1 is related to proliferation, survival and poor prognosis in pancreatic cancer.Bmi-1 与胰腺癌的增殖、存活和不良预后有关。
Cancer Sci. 2010 Jul;101(7):1754-60. doi: 10.1111/j.1349-7006.2010.01577.x. Epub 2010 Mar 24.
8
Heterogeneity for stem cell-related markers according to tumor subtype and histologic stage in breast cancer.乳腺癌中根据肿瘤亚型和组织学分期的干细胞相关标志物的异质性。
Clin Cancer Res. 2010 Feb 1;16(3):876-87. doi: 10.1158/1078-0432.CCR-09-1532. Epub 2010 Jan 26.
9
Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content.乳腺癌的生物学和分子异质性与其癌症干细胞含量相关。
Cell. 2010 Jan 8;140(1):62-73. doi: 10.1016/j.cell.2009.12.007.
10
Heterogeneity in cancer: cancer stem cells versus clonal evolution.癌症中的异质性:癌症干细胞与克隆进化
Cell. 2009 Sep 4;138(5):822-9. doi: 10.1016/j.cell.2009.08.017.